Switzer TV

 

Welcome back for another year of stock picks, top LICs and trading tips with Switzer Investing TV. Good to have you aboard.

On this kick-off ep for the new year, we're looking at roughed-up companies on the market that might be worth a second look. Quality stocks are being sold hard, resources are back in favour, and investors are asking the same uncomfortable question, is this a buying opportunity or a value trap?

In this first show of the year, Peter Switzer sits down with Adam Dawes from Shaw and Partners, Mike Gable from Fairmont Equities, and Paul Rickard from the Switzer Report to cut through the noise.

They run the ruler over some of the market’s most talked-about names, including CSL, NextDC, Xero, WiseTech, Pro Medicus, lithium plays, uranium stocks, and gold. Fundamentals meet charts, sentiment clashes with valuation, and the panel doesn’t always agree. You’ll hear why great businesses can fall a long way without anything being “wrong”, what the charts are really saying about beaten-up tech, why resources have momentum again, and whether gold is still a defensive play with upside in 2026.

Switzer Investing TV (19/12/25): Are these smashed stocks worth your time?

On this kick-off ep for the new year, we're looking at roughed-up companies on the market that might be worth a second look. Quality stocks are being sold hard, resources are back in favour, and investors are asking the same uncomfortable question, is this a buying opportunity or a value trap?

More videos

We shine the spotlight on these quality ASX stocks: ALU, BHP, MQG, CSL, TLS & more!

Julia Lee from Burman Invest, Adam Dawes from Shaw and Partners, Michael Gable from Fairmont Equities and Paul Rickard join Peter Switzer.

Series:
Philip Daffas from Painchek (ASX:PCK)

Peter Switzer is joined by Philip Daffas, the CEO and Managing Director of Painchek (PCK).

Series:
How drinking coffee could be good for you

Dr Ross Walker talks about a study undertaken in Japan around diabetics consuming multiple cups of coffee and green tea a day. The results are surprising.

Series:
Mad about Money Live

Join Peter Switzer and Paul Rickard to hear about the big money stories of the day and how they affect you.

Series:
Beaten up quality stocks to buy: CSL, JBH, TWE, A2M, MND, TYR & Tesla?

Peter Switzer is joined by Tribeca's Jun Bei Liu, Burman Invest's Julia Lee and Switzer's Paul Rickard.

Series:
Are artificially sweetened soft drinks better for you?

Dr Ross Walker tells us facts from a study of people who drank artificially sweetened drinks and the results are alarming.

Series:
Mad about Money Live

Peter Switzer and Paul Rickard discuss the big money stories you need to know about.

Series:
Stocks that will rise on vaccination - (ASX: A2M, EVT, AVH, SGR, CSL, APX, ELO)

Peter Switzer speaks to Adam Dawes, Paul Rickard, Danny Lessem and David Dicker.

Series:
What happens if you drink a can of soft drink every day?

Dr Ross Walker explains how regularly drinking soft drinks negatively affects your health.

Series:
Mad about Money Live

Join Peter Switzer and Paul Rickard for their take on the latest money news in Mad about Money.

Series:
Experts love these ASX stocks: TYR, IGO, APX, AVH, WES, OML, XRO

Tribeca's Jun Bei Liu, Switzer's Paul Rickard, Burman Invest's Julia Lee and Aussie Broadband's Phillip Britt join Peter Switzer.

Series:
The best options for a coronary artery bypass graft

Dr Ross Walker explains what coronary artery bypass grafting is and what the best types are.

Series:
1 34 35 36 37 38 51

Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox

Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
© 2006-2021 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
shopping-cartphoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram